The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
J&J Must Pay $2.1B to Women in Talc Ovarian Cancer Litigation
Milestone Consulting, LLC
(716) 883-1833

We at Milestone want to cheer from the rooftops when a person or group of people prevail against a corporation that harmed them, and today is no different. A three-judge panel in the Missouri Court of Appeals for the Eastern District upheld the verdict against Johnson & Johnson over claims that link its talc-based baby powders to ovarian cancer. The company will have to pay $2.1 billion to the women and families who bravely stood up to J&J for knowingly using asbestos-laced talc in its products.

In yesterday’s 83-page opinion, the Missouri judges said expert testimony from 2018 regarding asbestos exposure was based on reasonable methodology and was a legitimate basis for holding J&J liable for the cancer that women developed after using its talc-based powders. The panel upheld the $500 million in actual damages originally awarded to the women but cut punitive damages to about $1.6 billion. 

“The opinion carefully explains the reprehensible conduct of J&J, and upholds critical damages to make the world a safer place,” said attorney Mark Lanier, who represents the plaintiffs. 

Lanier has been working for years to make J&J take responsibility for continuing to sell its baby powders for decades while knowing about the connection to ovarian cancer. Last month, when the company said it would cease manufacturing products containing talc, he welcomed the announcement but noted that more work needed to be done. “We anticipate trying these cases and doing our absolute best to prevail again and again,” Lanier said. “Today’s action by the company will stop future exposure, but justice still needs pursuing for those exposed and harmed in the past.” 

Yesterday was a huge step toward obtaining that justice for the families all over the country who have been impacted by these dangerous products. Congratulations to Mark Lanier and the plaintiffs’ team on this victory.

Join the Discussion

Your email address will not be published. Required fields are marked *.

Please do not include personal details in your comment. To message the author privately instead, click here.

Contacting the author via this website, either publicly or privately, does not create an attorney–client privilege.